Get the Stockscreener App
7.565
0.73%
0.025
Journey Medical Corp stock is traded at $7.565, with a volume of 39,143.
It is up +0.73% in the last 24 hours and up +16.85% over the past month.
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
See More
Previous Close:
$7.54
Open:
$7.55
24h Volume:
39,143
Relative Volume:
0.42
Market Cap:
$131.39M
Revenue:
$56.13M
Net Income/Loss:
$-14.67M
P/E Ratio:
-10.22
EPS:
-0.74
Net Cash Flow:
$-9.13M
1W Performance:
-5.77%
1M Performance:
+16.85%
6M Performance:
+41.96%
1Y Performance:
+62.29%
1-Day Range:
$7.4381
$7.75
1-Week Range:
$7.01
$8.2487
52-Week Range:
$3.535
$8.2487
Journey Medical Corp Stock (DERM) Company Profile
Name
Journey Medical Corp
Sector
Phone
480-434-6670
Address
9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE
Compare DERM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DERM
Journey Medical Corp
|
7.595 | 188.00M | 56.13M | -14.67M | -9.13M | -0.74 |
|
HLN
Haleon Plc Adr
|
11.07 | 50.98B | 14.35B | 1.85B | 0 | 0.4023 |
|
ZTS
Zoetis Inc
|
169.83 | 74.41B | 9.29B | 2.52B | 2.28B | 5.57 |
|
RDHL
Redhill Biopharma Ltd Adr
|
1.9308 | 4.03M | 35.75M | 11.57M | -26.25M | -3.8069 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.94 | 46.23B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.77 | 20.10B | 16.54B | -1.64B | 749.00M | -1.45 |
Journey Medical Corp Stock (DERM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-22-24 | Initiated | Rodman & Renshaw | Buy |
| Jun-28-24 | Resumed | ROTH MKM | Buy |
| Dec-07-21 | Initiated | B. Riley Securities | Buy |
Journey Medical Corp Stock (DERM) Latest News
Journey Medical stock soars to 52-week high of $8.25 - Investing.com India
Journey Medical stock soars to 52-week high of $8.25 By Investing.com - Investing.com Nigeria
Tang Capital Management LLC Buys Shares of 1,725,569 Journey Medical Co. (NASDAQ:DERM) - MarketBeat
Contrasting Amarantus BioScience (OTCMKTS:AMBS) and Journey Medical (NASDAQ:DERM) - Defense World
Q2 EPS Estimates for Journey Medical Reduced by Roth Capital - MarketBeat
Journey Medical Q2 EPS Forecast Decreased by Roth Capital - Defense World
20,455 Shares in Journey Medical Co. (NASDAQ:DERM) Purchased by Dimensional Fund Advisors LP - Defense World
Journey Medical price target lowered to $10 from $10.50 at Alliance Global - TipRanks
Trading Resumes for Journey Medical (DERM) Corp | DERM Stock New - GuruFocus
Fortress Biotech Earnings: Triple Win with $28M Checkpoint Deal, FDA Fast-Track, and Rosacea Drug Launch - Stock Titan
Journey Medical (DERM) Surpasses Q1 Revenue Expectations with Su - GuruFocus
Alliance Global Partners Revises Price Target for Journey Medica - GuruFocus
DERM Stock Trading Halted Due to Volatility | DERM Stock News - GuruFocus
Alliance Global Partners Revises Price Target for Journey Medical (DERM) | DERM Stock News - GuruFocus
Journey Medical Corp SEC 10-Q Report - TradingView
Journey Medical Q1 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Journey Medical Q1 2025 reports revenue beat - Investing.com Australia
Journey Medical reports Q1 EPS (18c) vs. (53c) last year - TipRanks
Earnings call transcript: Journey Medical Q1 2025 reports revenue beat By Investing.com - Investing.com UK
Journey Medical earnings missed by $0.08, revenue topped estimates - Investing.com
Journey Medical Corporation (DERM) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Journey Medical Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Journey Medical Corporation Reports First Quarter 2025 Financial Results - TradingView
Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights - The Globe and Mail
What To Expect From Journey Medical Corp (DERM) Q1 2025 Earnings - GuruFocus
Care Transition Startup Kouper Lands $10M in Funding - Healthcare Innovation
Aurinia Pharmaceuticals (AUPH) Surpasses Q1 Earnings and Revenue Estimates - Yahoo Finance
Journey Medical (DERM) to Release Quarterly Earnings on Wednesday - Defense World
Dr. Michael Lebow Scholarship Announces Scholarship to Cultivate Future Medical Leaders - Newsfile
Journey Medical (DERM) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
The Joint Corp. (JYNT) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025 - Stock Titan
Journey Medical (NASDAQ:DERM) Shares Down 1.6%Here's Why - MarketBeat
Top Executives at Journey Medical Corp Make Major Stock Moves! - TipRanks
Journey Medical Co. (NASDAQ:DERM) Shares Sold by Envestnet Asset Management Inc. - Defense World
Journey Medical Corp Executives Sell Shares to Cover Tax Obligations - TradingView
Journey Medical Co. (NASDAQ:DERM) Short Interest Up 68.0% in April - MarketBeat
McKesson Careers | The future of health starts with you. - McKesson Careers
Renaissance Technologies LLC Lowers Position in Journey Medical Co. (NASDAQ:DERM) - Defense World
Why Journey Medical Corporation (DERM) is Surging in 2025 - Insider Monkey
SEC Form DEF 14A filed by Journey Medical Corporation - Quantisnow
Why These 15 Healthcare Stocks Are Surging in 2025 - Insider Monkey
Azurite Medical and Wellness Launches Revolutionary Luxury Surgical Retreat Concept in Global Medical Tourism Market - Yahoo Finance
Navigating MBOT Stock: Microbot Medical Inc Journey - investchronicle.com
Journey Medical Co. (NASDAQ:DERM) Short Interest Update - MarketBeat
Journey Medical Corp Stock (DERM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.77%
0.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):